Tag: GO2 Foundation for Lung Cancer
-
The WHAM Report: Investing Just $40 Million New Dollars in Lung Cancer Research Related to Women Has Dramatic Impact on U.S. Economy
Lung cancer kills more women in the U.S. than breast, ovarian and cervical cancers combined. The report commissioned by Women’s Health Access Matters (WHAM) is based on novel microsimulation modeling from the RAND Corporation and documentation consistent with previous analyses on women and Alzheimer’s, coronary artery disease and rheumatoid arthritis. Greenwich, CT (November 1, 2022)—Doubling…
-
GO2 Foundation for Lung Cancer Honors Key Partner in Fight Against Lung Cancer
SAN CARLOS, Calif. and WASHINGTON – GO2 Foundation for Lung Cancer (GO2 Foundation) announced it will honor Daiichi Sankyo with the “Simply the Best Award” for their commitment to advancing lung cancer oncology discovery to meet the needs of all patients. The company will accept the award at the Simply the Best XVII Dinner and Gala on…
-
Presidential Proclamation Designates November as National Lung Cancer Awareness Month
As we come together to commemorate Lung Cancer Awareness Month, we are excited to share that President and First Lady Biden who just issued a Presidential Proclamation designating November 2022 as National Lung Cancer Awareness Month! GO2 is honored to have partnered with the White House in developing this message which raises much-needed awareness of…
-
Advances in Precision Medicine for Late Stage Lung Cancer
Authors: Renee Botello, MSc., Treatment and Trials Navigator; Andrew Ciupek, PhD, Associate Director, Clinical Research; Chief Scientific Officer Jennifer C. King, PhD; Shanada Monestime, PharmD, BCOP, Director, Community Engaged Research The Current Landscape of Oncogene Targeted Therapies EGFR: There was a focus on treating EGFR-positive NSCLC that has progressed after being treated with currently approved…
-
GO2 Foundation’s Presence at The World Conference on Lung Cancer 2022
Author: Brittney Nichols, MPH, BSN-RN, Specialist, Science and Research This summer, the World Conference on Lung Cancer convened in Vienna, Austria. GO2 shared our research with this community as both lead authors and collaborators on several projects to help advance the diagnosis, treatment, and survival of people with lung cancer. SHAWL Study The GO2 Foundation…
-
Advances in Treatment for Early Stage Non-Small Cell Lung Cancer
Author: Daniel A. Saez, MSc, Manager, LungMATCH Navigation Program For many years, the treatment options given to patients diagnosed with early stage non-small cell lung cancer (NSCLC) was limited to surgery with or without chemotherapy to improve outcomes. However, like with metastatic NSCLC, the treatment landscape for patients with early-stage NSCLC has shifted much more…
-
Jennifer Moran on Finding Inspiration – and Inspiring Others
Participating in Research Offers Her Hope of Changing the Course of Lung Cancer Jennifer Moran is married to her high school sweetheart. They have two teenage children in college. A photography major who once dreamed of working at National Geographic, she fell into “a wonderful career in ophthalmic photography.” At age 48, she was diagnosed…
-
GO Foundation’s Kathy Levy a Finalist for Prestigious Catalyst for Equity Award
We’re delighted to announce that Kathy Levy, GO2 Foundation’s ALCASE Project Manager, was a finalist for the prestigious C2 Catalyst for Equity award. The award recognizes people who have worked to overcome longstanding racial and ethnic disparities in cancer care, ensuring that all people have equitable access to quality care. Kathy Levy, Manager, ALCASE Project…
-
Living Room Recap – Options and Next Steps If Your Lung Cancer Becomes Resistant to Your Course of Treatment
What happens when your cancer becomes resistant to your course of treatment and progresses? That’s the question we explored in the September episode of our Lung Cancer Living Room series. Dr. David Gandara, professor emeritus and co-director of UC Davis Comprehensive Cancer Center’s Center for Experimental Therapeutics, discussed a number of options. The good news…
-
Juanita Segura is Inspiring Hope in the Lung Cancer Community
Juanita Segura is a ray of hope in the fight against lung cancer. As a result, she has been awarded the 2022 Rays of Hope Award for her leadership and for inspiring hope as we work together as a community to conquer lung cancer. Upon receiving the award on May 17, Segura said that “being…
Raju Reddy MD, Pittsburgh 